insulin

Lawmakers Consider Bill To Rein In High Insulin Prices

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

Oregon lawmakers are looking for ways to keep insulin prices in check for patients who need the drug to stay alive.

Bill Aims To Prevent More Deaths By Allowing Pharmacists To Fill Emergency Insulin Orders

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

Oregon lawmakers have introduced legislation that would avert a crisis for a diabetic in need of insulin.

Insulin’s High Cost Leads To Deadly Rationing

The price of insulin in the U.S. has more than doubled since 2012, putting the life-saving hormone out of reach for some people with diabetes.

Diabetic ketoacidosis is a terrible way to die. It’s what happens when you don’t have enough insulin. Your blood sugar gets so high that your blood becomes highly acidic, your cells dehydrate, and your body stops functioning.

The Type 1 Diabetes Defense Foundation Files New Lawsuits Alleging Overpricing, Requesting Disclosure of Manufacturers’ Effective Net Realized Prices for Test Strips, Glucagon

Summary: On May 24, 2017, the Type 1 Diabetes Defense Foundation filed two new lawsuits in federal court with class-action law firm Keller Rohrback, L.L.P., seeking disclosure of manufacturers’ net realized prices on blood glucose test strips and emergency glucagon kits, both used in diabetes treatment. Following on T1DF’s insulin pricing lawsuit filed March 17, 2017 (Boss, et al. v. CVS, et al.), T1DF now joins with individual plaintiffs in test strip claim Prescott, et al. v. CVS, et al. and glucagon claim Bewley, et al. v. CVS, et al., expanding its consumer rights campaign against the unconscionable pricing of essential pharmaceuticals. These lawsuits are consistent with T1DF’s opposition to “rebates” and other hidden pricing practices that raise list prices for diabetes drugs and supplies while disincentivizing innovation, promoting clinical inertia, undermining therapeutic adherence and encouraging discrimination against people with diabetes.

June 15, 2017 - Eugene, OR. Glucagon rescue kits provide an emergency injection of glucagon, a hormone that raises blood sugar, in case of life-threatening severe low blood sugar.

Subscribe to insulin